Search results
30 kwi 2018 · As a cause of significant morbidity and mortality, infection with hepatitis E virus (HEV) represents an important global public health problem. The European Association for the Study of Liver (EASL) invited a panel of experts in the field to develop Clinical Practice Guidelines (CPGs) with a particular focus on HEV geno-type (gt) 3.
Infection with hepatitis E virus (HEV) is a significant cause of morbidity and mortality, representing an important global health problem. Our understanding of HEV has changed completely over the past decade.
9 sie 2023 · INTRODUCTION. Hepatitis E virus (HEV) is one of the most common causes, yet least diagnosed etiologies, of acute viral hepatitis [1]. HEV infection has a global distribution, with distinct differences in transmission and disease outcomes in resource-rich versus resource-limited areas.
1 mar 2024 · Hepatitis E is a globally distributed infection that varies in seroprevalence between developed and developing regions. In the less developed regions of Asia and Africa, a high seropositivity rate has been reported for hepatitis E virus (HEV) antibodies.
17 lip 2020 · Ribavirin therapy for a period of 3 months is the drug of choice for severe acute hepatitis, acute-on chronic liver failure, and chronic infections from hepatitis E virus in immunocompromised patients who are unresponsive to decreased immunosuppression.
26 cze 2023 · It causes acute, self-limited hepatitis in immunocompetent hosts and chronic hepatitis in immunosuppressed patients. This activity illustrates the evaluation and management of hepatitis E infection and reviews the role of the interprofessional team in improving care for patients with this condition. Objectives:
20 gru 2020 · Hepatitis E virus infection can cause chronic hepatitis in immunocompromised patients with significant chance of progressive fibrosis and possibly cirrhosis. The aim of this systematic review was to summarize the efficacy and safety of the various treatment options for chronic hepatitis E.
